Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection

被引:27
作者
Di Sandro, S. [1 ,2 ]
Benuzzi, L. [1 ,2 ]
Lauterio, A. [1 ,2 ]
Botta, F. [3 ]
De Carlis, R. [1 ,4 ]
Najjar, M. [5 ]
Centonze, L. [1 ]
Danieli, M. [1 ,2 ]
Pezzoli, I [1 ,2 ]
Rampoldi, A. [1 ]
Bagnardi, V [3 ]
De Carlis, L. [1 ,2 ,6 ]
机构
[1] Osped Niguarda Ca Granda, Dept Gen Surg & Transplantat, Milan, Italy
[2] Osped Niguarda Ca Granda, Niguarda Transplant Fdn, Milan, Italy
[3] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
[4] Univ Pavia, Dept Surg Sci, Pavia, Italy
[5] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Ctr Liver Dis & Transplantat, New York, NY USA
[6] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy
来源
EJSO | 2019年 / 45卷 / 09期
关键词
Hepatocellular carcinoma; Laparoscopy; Liver resection; Radiofrequency ablation; HEPATIC RESECTION; LOCAL RECURRENCE; TRANSPLANTATION; CLASSIFICATION; COMPLICATIONS; MANAGEMENT; SURGERY; COHORT;
D O I
10.1016/j.ejso.2019.04.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Patients with a single small Hepatocellular Carcinoma (HCC) may be definitively treated by Radiofrequency ablation (RFA) with a very low rate of peri-operative morbidity. However, results are still controversial comparing RFA to Liver Resection (LR). Methods: All consecutive patients treated by RFA or LR for a single untreated small HCC on liver cirrhosis between January 2006-December 2016 were enrolled. Patients were matched 1:1 basing on: age, MELD-score, platelet count, nodule's diameter, HCV status, alpha-fetoprotein level, and Albumin-Bilirubin score. First analysis compered LR to RFA. Second analysis compared Laparoscopic LR (LLR) to RFA. Results: Of 484 patients with single small HCC, 91 patients were selected for each group after a 1:1 propensity score matching (PS-M). The 5-years OS was 70% and 60% respectively for LR and RFA group (P = 0.666). The 5-year RFS was 36% and 21% respectively for LR and RFA group (P < 0.001). Patients treated by LR had a significantly longer hospital stay and higher complications rate. Comparing 50 cases of LLR and 50 of RFA, the 5-years OS was 79% and 56% respectively for LLR and RFA group (P = 0.22). The 5-year RFS was 54% and 19% respectively for LR and RFA group (P < 0.001). Post-operative complications were not significantly different. Conclusions: LLR confers similar peri-operative complications rate compared to RFA. LLR should be considered as a first-line approach for the treatment of a single small HCC as it combines the effectiveness of open LR and the safety profile of RFA. (C) 2019 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1691 / 1699
页数:9
相关论文
共 35 条
[1]  
[Anonymous], 1988, Statistical power analysis for the behavioral sciences
[2]   Laparoscopic Liver Resection-Understanding its Role in Current Practice The Henri Mondor Hospital Experience [J].
Bryant, Richard ;
Laurent, Alexis ;
Tayar, Claude ;
Cherqui, Daniel .
ANNALS OF SURGERY, 2009, 250 (01) :103-111
[3]   The International Position on Laparoscopic Liver Surgery The Louisville Statement, 2008 [J].
Buell, Joseph F. ;
Cherqui, Daniel ;
Geller, David A. ;
O'Rourke, Nicholas ;
Iannitti, David ;
Dagher, Ibrahim ;
Koffron, Alan J. ;
Thomas, Mark ;
Gayet, Brice ;
Han, Ho Seong ;
Wakabayashi, Go ;
Belli, Giulio ;
Kaneko, Hironori ;
Ker, Chen-Guo ;
Scatton, Olivier ;
Laurent, Alexis ;
Abdalla, Eddie K. ;
Chaudhury, Prosanto ;
Dutson, Erik ;
Gamblin, Clark ;
D'Angelica, Michael ;
Nagorney, David ;
Testa, Giuliano ;
Labow, Daniel ;
Manas, Derrik ;
Poon, Ronnie T. ;
Nelson, Heidi ;
Martin, Robert ;
Clary, Bryan ;
Pinson, Wright C. ;
Martinie, John ;
Vauthey, Jean-Nicolas ;
Goldstein, Robert ;
Roayaie, Sasan ;
Barlet, David ;
Espat, Joseph ;
Abecassis, Michael ;
Rees, Myrddin ;
Fong, Yuman ;
McMasters, Kelly M. ;
Broelsch, Christoph ;
Busuttil, Ron ;
Belghiti, Jacques ;
Strasberg, Steven ;
Chari, Ravi S. .
ANNALS OF SURGERY, 2009, 250 (05) :825-830
[4]   Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing [J].
Ciria, Ruben ;
Cherqui, Daniel ;
Geller, David A. ;
Briceno, Javier ;
Wakabayashi, Go .
ANNALS OF SURGERY, 2016, 263 (04) :761-777
[5]   Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma [J].
Cucchetti, A. ;
Mazzaferro, V. ;
Pinna, A. D. ;
Sposito, C. ;
Golfieri, R. ;
Serra, C. ;
Spreafico, C. ;
Piscaglia, F. ;
Cappelli, A. ;
Bongini, M. ;
Cucchi, M. ;
Cescon, M. .
BRITISH JOURNAL OF SURGERY, 2017, 104 (12) :1704-1712
[6]   Liver Transplantation for Hepatocellular Carcinoma Recurrence After Liver Resection Why Deny This Chance of Cure? [J].
De Carlis, Luciano ;
Di Sandro, Stefano ;
Giacomoni, Alessandro ;
Mangoni, Iacopo ;
Lauterio, Andrea ;
Mihaylov, Plamen ;
Cusumano, Caterina ;
Rampoldi, Antonio .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (04) :352-358
[7]   Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis [J].
Di Sandro, Stefano ;
Bagnardi, Vincenzo ;
Najjar, Marc ;
Buscemi, Vincenzo ;
Lauterio, Andrea ;
De Carlis, Riccardo ;
Danieli, Maria ;
Pinotti, Enrico ;
Benuzzi, Laura ;
De Carlis, Luciano .
SURGICAL ONCOLOGY-OXFORD, 2018, 27 (04) :722-729
[8]   Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients [J].
Di Sandro, Stefano ;
Sposito, Carlo ;
Lauterio, Andrea ;
Najjar, Marc ;
Busset, Michele Droz Dit ;
Buscemi, Vincenzo ;
Reyes, Maria Flores ;
De Carlis, Riccardo ;
Mazzaferro, Vincenzo ;
De Carlis, Luciano .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) :1147-1159
[9]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[10]  
European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI [10.1016/j.ejca.2011.12.021, 10.1016/j.jhep.2011.12.001]